Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential

Xiaojie Lin1, Yan Fang1, Xuechao Jin1

  • 1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 117004, P. R. China.

ACS Applied Bio Materials
|January 10, 2022
PubMed

Insights

Nanoparticles can reprogram tumor-associated macrophages (TAMs) to enhance cancer immunotherapy. This approach targets M2 macrophages, reducing immunosuppression within the tumor microenvironment (TME) for better treatment outcomes.

Area of Science:

  • Immunology
  • Nanotechnology
  • Oncology

Background:

  • Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) promote immune evasion, leading to tumor growth and therapeutic resistance.
  • Macrophages exhibit plasticity, differentiating into M1 (inflammatory) and M2 (regulatory) phenotypes, influencing immune responses.
  • Understanding macrophage polarization is crucial for developing effective cancer immunotherapies.

Purpose of the Study:

  • To review the application of nanopreparations in macrophage-centered immunotherapy.
  • To explore how nanotherapeutics can modulate TAM phenotypes and functions within the TME.
  • To provide insights into targeting macrophage plasticity for cancer treatment.

Main Methods:

  • Review of literature on macrophage biology, TME components, and nanoparticle-based drug delivery.
  • Analysis of signaling pathways regulating macrophage polarization (M1/M2).
  • Evaluation of nanotherapeutics designed to attenuate M2 macrophages and reduce TME immunosuppression.

Main Results:

  • Nanopreparations can be engineered to target and re-educate TAMs, shifting their phenotype from immunosuppressive M2 to anti-tumorigenic states.
  • Targeted nanoparticles can reduce M2 macrophage aggregation in the TME, thereby alleviating immunosuppression.
  • Detailed mechanisms of key signaling pathways governing macrophage plasticity and polarization are elucidated.

Conclusions:

  • Macrophage-targeted nanopreparations offer a promising strategy for cancer immunotherapy by modulating the TME.
  • Nanotherapeutics can overcome challenges associated with TAM-driven immunosuppression.
  • This review provides a foundation for developing novel diagnostic and therapeutic strategies centered on macrophage manipulation in various diseases.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K